Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Tarantolo

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantationM R Bishop, S R Tarantolo, Z S Pavletic, et al.
Bone Marrow Transplantation|July 23, 1998
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two casesR J Hauke, T C Greiner, B N Smir, et al.
Lancet (London, England)|January 1, 1999
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantationR E Brand, J K DiBaise, E M Quigley, et al.
International Journal of Oncology|September 15, 1998
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cellsS S Joshi, N N Babushkina-Patz, D J Verbik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantationW D Haire, E I Ruby, L C Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignanciesD L Darrington, J M Vose, J R Anderson, et al.
Bone Marrow Transplantation|December 11, 2012
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT)J A Steuter, M L H Villanueva, F R Loberiza, et al.
The New England Journal of Medicine|June 15, 2000
Thrombotic thrombocytopenic purpura associated with clopidogrelC L Bennett, J M Connors, J M Carwile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignanciesZ S Pavletic, M R Bishop, S R Tarantolo, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantationM R Bishop, S R Tarantolo, Z S Pavletic, et al.
Bone Marrow Transplantation|July 23, 1998
Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two casesR J Hauke, T C Greiner, B N Smir, et al.
Lancet (London, England)|January 1, 1999
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantationR E Brand, J K DiBaise, E M Quigley, et al.
International Journal of Oncology|September 15, 1998
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cellsS S Joshi, N N Babushkina-Patz, D J Verbik, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantationW D Haire, E I Ruby, L C Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignanciesD L Darrington, J M Vose, J R Anderson, et al.
Bone Marrow Transplantation|December 11, 2012
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT)J A Steuter, M L H Villanueva, F R Loberiza, et al.
The New England Journal of Medicine|June 15, 2000
Thrombotic thrombocytopenic purpura associated with clopidogrelC L Bennett, J M Connors, J M Carwile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignanciesZ S Pavletic, M R Bishop, S R Tarantolo, et al.
Blood|July 13, 2000
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantationM R Bishop, S R Tarantolo, R B Geller, et al.
Pageof 3